SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-027804
Filing Date
2018-05-14
Accepted
2018-05-14 08:01:10
Documents
40
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv491824_10q.htm 10-Q 288753
2 EXHIBIT 31.1 tv491824_ex31-1.htm EX-31.1 7360
3 EXHIBIT 31.2 tv491824_ex31-2.htm EX-31.2 7322
4 EXHIBIT 32.1 tv491824_ex32-1.htm EX-32.1 3892
5 EXHIBIT 32.2 tv491824_ex32-2.htm EX-32.2 3980
  Complete submission text file 0001144204-18-027804.txt   1878818

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bcli-20180331.xml EX-101.INS 259254
7 XBRL TAXONOMY EXTENSION SCHEMA bcli-20180331.xsd EX-101.SCH 25846
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcli-20180331_cal.xml EX-101.CAL 18930
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcli-20180331_def.xml EX-101.DEF 148085
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20180331_lab.xml EX-101.LAB 188993
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20180331_pre.xml EX-101.PRE 164359
Mailing Address 1745 BROADWAY, 17TH FLOOR NEW YORK NY 10019
Business Address 1745 BROADWAY, 17TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36641 | Film No.: 18828712
SIC: 2836 Biological Products, (No Diagnostic Substances)